Sophia Antipolis, 16 November 2021 : European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic is published today in the European Heart Journal . 1-2
This guidance brought together a large number of key opinion leaders at the outset of the pandemic. The advice was first published on the ESC website to be regularly updated, and is now provided as a journal publication.
The two-part document provides practical information and advice to help clinicians diagnose and manage cardiovascular disease in patients with COVID-19.
Part one includes:
Part two includes:
The authors note that the papers summarise current knowledge and guidance: “The recommendations are mainly the result of observations and personal experience from healthcare providers [in Europe]. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.”
ENDS
Authors: ESC Press Office
Mobile: +33 (0)7 8531 2036
Email: press@escardio.org
Follow us on Twitter @ESCardioNews
Notes to editor
References
1 European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis. Eur Heart J . 2021. doi:10.1093/eurheartj/ehab696.
Link will go live on publication:
https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehab696
2 ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up. Eur Heart J . 2021. doi:10.1093/eurheartj/ehab697.
https://academic.oup.com/eurheartj/article-lookup/doi/10.1093/eurheartj/ehab697
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
European Heart Journal